Exploiting Temozolomide-Induced Hypermutation With Pembrolizumab in a Refractory High-Grade Neuroendocrine Neoplasm: A Proof-of-Concept Case
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details